Molecular Diagnostics
Blood Test for Symptomatic Patients Aims to Revolutionize Cancer Diagnosis
A novel blood test, capable of detecting over 50 types of cancer, has shown promising results, accurately detecting cancer in two-thirds of more than 5,000 individuals who had consulted their physician due to suspected symptoms. More...05 Jun 2023
CRISPR-Powered Method for Non-Invasive Blood Tests to Help Diagnose Early Stage Cancer
Earlier CRISPR tests were not as sensitive as the gold standard RT-qPCR and involved multistep reactions with manual handling. Now, a new approach, called “EXTRA-CRISPR,” could represent a game-changing method in the microRNA testing field. More...02 Jun 2023
New Diagnostic Approach Combines DNA Testing With AI Analysis for Coronary Heart Disease Risk Assessment
A revolutionary test utilizes epigenetics, genetics, artificial intelligence, and machine learning to more accurately and cost-effectively detect early signs of cardiovascular disease. More...31 May 2023
Novel Blood Serum Assay Enables Quicker Diagnosis of Neurodegenerative Diseases
Scientists have developed a novel assay capable of effectively identifying α-synuclein seeds in a patient's serum, enabling accurate diagnosis and monitoring of treatment of neurodegenerative diseases. More...31 May 2023
Handheld Multiplexed Biosensor Platform Tests Antibodies, Antigens and Molecular Targets Simultaneously
A pioneering, portable, multiplex biosensor platform has the ability to simultaneously test antibodies, antigens, and molecular targets, enabling handheld, laboratory-grade testing wherever required. More...30 May 2023
Gold Member
Chagas Disease Test
CHAGAS Cassette
New
Cytomegalovirus Test
NovaLisa Cytomegalovirus (CMV) IgG Test
 RapiCardTM InstaTest (Serum-WB-Plasma).jpg)
New
C-Reactive Protein Assay
OneStep C-Reactive Protein (CRP) RapiCard InstaTest
In Other News
Blood- And Urine-Based Biomarker Tests Could Identify Treatment of Acute Kidney Injury
Synthetic Peptides to Pave Way for Diagnostic Tests to Detect Inflammatory Diseases
Innovative All-in-One MDx Platform Addresses Needs of Medium-to-High Throughput Laboratories
World's First Fully Integrated Platform for Automated High Molecular Weight DNA Extraction
Breakthrough Immunoassays to Aid in Risk Assessment of Preeclampsia
Paper Strip Test Detects Hypothyroidism Using Small Drop of Blood
Game-Changing 10-Minute POC PCR Testing Platform Delivers Lab-Quality Results
Cartridge-Based Antigen Testing System Delivers PCR Equivalent Performance at Half the Price
Blood Test Taken After Miscarriage Can Predict Future Risk of Pregnancy Loss
Urine Test Detects Parkinson’s by Identifying Protein from Brain Cells
New Liquid Biopsy Approach 30% More Sensitive in Detecting Tumor DNA in Blood
Next Generation Immunoassay Analyzer Boasts Industry’s Highest Throughput per Footprint
AI-Powered Test Predicts Risk of Developing Esophageal Cancer in Patients with Barrett’s Esophagus
Ultrafast, Low-Cost Point-of-Care PCR Testing System Provides Central Lab Precision in 15 Minutes
Fully-Automated Chemiluminescence Analyzer Enables Fast, Convenient Testing in Clinical and Emergency Settings
Novel PCR Testing Device Represents Technological Leap in POC Infectious Disease Diagnostics
Rapid POC Salivary Diagnostic Technology Shows Potential for Detecting Various Disease Biomarkers
Multiplex Real-Time PCR Assay Simultaneously Detects and Identifies 9 Parasitic Gastrointestinal Pathogens
New Technique Rapidly Detects Needle-in-a-Haystack Plasma Biomarkers for Disease Diagnosis
DNA Test Detects Esophageal Precancer and Cancer at POC without Endoscopy
Portable POCT Immunofluorescence Analyzer Makes Testing Smarter, Faster and More Efficient
Groundbreaking Diagnostic Technique Enables Faster and More Accurate Detection of Neurodegenerative Diseases
Novel Pancreatic Cancer Screening Test to Combine DNA and Microbiome Biomarkers for Early-Stage Detection
Genetic Testing channel of LabMedica brings the latest in molecular genetics, cytogenetics, and epigenetics, and methods from PCR to FISH, and more.